Skip to main content
. 2021 Sep 13;9(9):e003032. doi: 10.1136/jitc-2021-003032

Figure 1.

Figure 1

ICB has revolutionized the MPM clinical landscape. (A) Clinical trials of ICB interventions organized on a timeline according to initial publication of results.4 5 120–123 (B) Details of ICB trials highlighted in A. Chemo, chemotherapy; ICB, immune checkpoint blockade; Ipi, ipilimumab; mOS, median overall survival; mPFS, median progression-free survival; MPM, malignant pleural mesothelioma; N/A, not available at time of writing; Nivo, nivolumab; ORR, object response rate; Pembro, pembrolizumab; Plac, placebo; Trem, tremelimumab.